Vascular Web Logo

SVS  SVS Foundation
A A A
VascularWeb

 Wednesday, June 15, 2011

All sessions and events occur in McCormick Place, Lakeside Center unless otherwise noted. Schedule is subject to change.

Postgraduate courses are offered for an additional fee.

​6:00 am – 5:00 pm POSTGRADUATE COURSES
6:00 am – 7:00 am​ Postgraduate Courses Registration and Breakfast
Room: 450 Foyer

7:00 am – 10:00 am
P1: Care of the Diabetic Foot from Wound Management to Revascularization
Room: 450a

At the end of the session, participants should be able to:

  1. Describe the critical role of non-vascular specialists in achieving wound healing success.
  2. Compare the advantages and disadvantages of various types of conduits, adjuncts and outflow targets. 
  3. Discuss the limitations of conventional angiography in determining endovascular revascularization success.
  4. Identify patient specific factors that affect revascularization strategies.
  5. Explain the diagnosis and appropriate intervention for venous disease in the treatment of diabetic wounds.
  6. Cite current and evolving technologies in coronary revascularization that may contribute to better outcomes in diabetic tibial endovascular procedures.
Moderators: David H. Deaton, MD, FACS, Georgetown University Hospital, Washington, D.C.
Richard F. Neville, MD, George Washington University Medical Center, Washington, D.C.
7:00 am
Critical Elements to Building an Effective Wound Care Center
Christopher E. Attinger, MD, Georgetown University Hospital, Washington, D.C. 

7:15 am
Determining Success in Endovascular Tibial Interventions: When a Pretty Picture Isn't Enough
Mark P. Androes, MD, Vascular Health Alliance, Spartanburg, SC

7:30 am
Patient Tailored Strategies for Lower Extremity Interventions
Rabih A. Chaer, MD, University of Pittsburgh, Pittsburgh, PA 

7:45 am
Coronary Technologies in Tibial Intervention: Does It Make Sense? When?
David H. Deaton, MD, FACS, Georgetown University Hospital, Washington, D.C.

8:00 am
Panel Discussion

8:30 am
What Do Podiatrists and Other Specialties Contribute to Diabetic Limb Salvage?
John S. Steinberg, DPM, Georgetown University, Washington, D.C.

8:45 am
Prosthetic Tibial Bypass: Major or Minor Role?
Edward Y. Woo, MD, Hospital of the University of Pennsylvania, Philadelphia, PA

9:00 am
Venous Disease in the Diabetic: Incidence, Impact and Intervention
William A. Marston, MD, University of North Carolina School of Medicine, Chapel Hill, NC

9:15 am
Choosing the Best Target Artery and Method of Revascularization for Limb Salvage
Richard F. Neville, MD, George Washington University Medical Center, Washington, D.C.

9:30 am
Panel Discussion

7:00 am - 10:00 am
P2: All Things Medical
Room: 450b

At the end of the session, participants should be able to:
  1. Define the current and new anticoagulant indications, uses, and risks for vascular patients.
  2. Define the evaluation and medical therapies available to reduce perioperative cardiac events in vascular patients.
  3. State the evidence for use of peri-angioplasty/stenting antiplatelet therapies, including duration of use.
  4. List the main principles for hypertension management in the vascular patient with three common agents.
  5. Define the evaluation and preventative measures to reduce pulmonary and diabetic complications in vascular patients.

Moderators: Peter K. Henke, MD, University of Michigan, Ann Arbor, MI
Timothy F. Kresowik, MD, University of Iowa, Iowa City, IA

7:00 am
The Role of the New Anticoagulants in Perioperative Anticoagulant Management
Thomas W. Wakefield, MD, University of Michigan, Ann Arbor, MI

7:25 am
Preoperative Cardiac Evaluation: Separating Fact from Opinion
Joseph H. Rapp, MD, VA Medical Center, San Francisco, CA

7:50 am
Today’s Antiplatelet Therapy
Joseph P. Hart, MD, FACS, Medical University of South Carolina, Charleston, SC

8:15 am
Medical Management of Hypertension for the Vascular Surgeon: What's the Status of Beta-Blockers?
James B. Froehlich, MD, MPH, University of Michigan, Ann Arbor, MI

8:40 am
Statins and Other Agents for Vascular Inflammation
Christopher D. Owens, MD, MSc, University of California San Francisco Medical Center, San Francisco, CA

9:05 am
Preoperative Optimization for the Vascular Surgical Patient: It Is Not Just the Heart that Matters!
Gregory L. Moneta, MD, Oregon Health Sciences University, Portland, OR

9:30 am
Panel Discussion  
                                                                                                             
10:00 am – 10:15 am​ Coffee Break
Room: 450 Foyer

10:15 am – 1:15 pm
P3: Novel Venous Disease Treatment: Modernizing Your Vascular Surgery Practice
Room 450a 

At the end of the session, participants should be able to:  
  1. Discuss the risks for recurrent DVT, treatment for acute iliofemoral DVT and chronic stenosis, and indication and practice of ICV filters.
  2. Describe the evidence based treatment of superficial venous insufficiency and perforators.
  3. Explain the importance of venous registries and venous screening in your own practice.

Moderators: Robert L. McLafferty, MD, Southern Illinois University School of Medicine, Springfield, IL
Joseph D. Raffetto, MD, VA Boston Healthcare System, West Roxbury, MA

10:15 am
Acute DVT: How Will Management Change After the ATTRACT Trial? 
Anthony J. Comerota, MD, Jobst Vascular Center, Toledo, OH

10:30 am
Chronic DVT: What You Should Know About Risk for Recurrence?
Mark H. Meissner, MD, University of Washington, Seattle WA

10:45 am
IVC Filters: Indications, Techniques, Troubleshooting
David L. Gillespie, MD, University of Rochester, Rochester, NY

11:00 am
Iliofemoral Stenosis and Occlusions: Best Management Options
Seshadri Raju, MD, River Oaks Hospital, Flowood, MS

11:15 am
Panel Discussion

11:45 am
Venous Ablation: Best Practice and Evidence Based Guidelines
Cynthia K. Shortell, MD, Duke University Medical Center, Durham, NC

12:00 pm
Perforators: What Is All the Fuss About?
Peter Gloviczki, MD, Mayo Clinic, Rochester, MN

12:15 pm
AVF Venous Registry: Why It Matters?
Brajesh K. Lal, MD, University of Maryland Medical Center, Baltimore, MD

12:30 pm
AVF National Screening Program: Why It Really Matters?
Joseph R. Schneider, MD, PhD, Vascular and Interventional Program of Central DuPage Hospital, Winfield, IL

12:45 pm
Panel Discussion
10:15 am - 1:15 am
P4: Update on CT and Angio Imaging Advances
Room: 450b
At the end of the session, participants should be able to:
  1. Define the capabilities of state-of-the-art radiologic imaging modalities for vascular disease.
  2. Objectively analyze the capabilities of novel and emerging angio suite imaging technologies.
  3. Initiate the design of an endovascular suite or hybrid operating room.
  4. Limit patient and OR staff exposure to radiation.
  5. Recognize and prevent adverse reactions due to procedural contrast administration.
  6. Moderators: Roy K. Greenberg, MD, Cleveland Clinic Foundation, Cleveland, OH
    Benjamin M. Jackson, MD, Hospital of the University of Pennsylvania, Philadelphia, PA 

10:15 am
CT Basics: Data Acquisition, Reconstruction, and Gating - What Surgeons Need to Know
Harold I. Litt, MD, PhD, University of Pennsylvania, Philadelphia, PA

10:30 am
PACS Systems, Network Viewing, and the EMR 
Bill Boonn, MD, University of Pennsylvania, Philadelphia, PA

10:45 am
3D Reconstruction of CT/MR Data
Sandra Halliburton, PhD, The Cleveland Clinic, Cleveland, OH
Bill Boonn, MD, University of Pennsylvania, Philadelphia, PA

Planning Procedures from 3D Data:
10:55 am 
Carotid
Mark C. Wyers, MD, FACS, Beth Israel Deaconess Medical Center, Boston, MA

11:05 am 
Aortic
Mark A. Farber, MD, UNC Vascular Surgery, Chapel Hill, NC

11:15 am 
LE 
Bart E. Muhs, MD, Yale University School of Medicine, New Haven, CT

11:25 am
Panel Discussion

Angio Systems: What the Future Has in Store:

11:35 am 
Hardware 
Roy K. Greenberg, MD, Cleveland Clinic Foundation, Cleveland, OH 

11:45 am 
Software (Fusion Technology) 
Girma Tefera, MD, University of Wisconsin School of Medicine and Public Health, Madison, WI

11:55 am 
Integration of Imaging Modalities 
Alan B. Lumsden, MD, The Methodist Hospital, Houston, TX

12:05 pm
Hybrid Room Design Basics
Marshall E. Benjamin, MD, Maryland Vascular Center, Glen Burnie, MD

12:15 pm
Panel Discussion

12:30 pm
Radiation Exposure
Tara M. Mastracci, MD, The Cleveland Clinic, Cleveland, OH

12:45 pm
Contrast Options and Complication
William S. Stavropoulos, MD, University of Pennsylvania, Philadelphia, PA

12:55 pm
Panel Discussion
1:15 pm – 2:00 pm​ Postgraduate Courses Lunch 
Room: 450 Foyer

   
2:00 pm – 5:00 pm
P5: Tools, Tips and Tricks for AV Access
Room: 450a

At the end of the session, participants should be able to:

  • Describe dialysis access problems in special populations of patients. 
  • Assess the role of complex dialysis access techniques.
  • Discuss the current research and novel techniques in dialysis access.
  • Address current coding and reimbursement.

Moderators: Mark G. Davies, MD, PhD, Methodist DeBakey Heart and Vascular Center, Houston, TX
Anil P. Hingorani, MD, Maimonides Medical Center, Brooklyn, NY

2:00 pm
What the Nephrologists Use to Evaluate Access Function . . . or How to Understand Their Language
Samuel R. Money, MD, FACS, Mayo Clinic, Phoenix, AZ

2:10 pm
Central Venous Stenosis: Can We Keep Them Open?
George H. Meier, MD, FACS, University of Cincinnati School of Medicine, Cincinnati,
OH 

2:20 pm
Steal Syndrome and Ischemic Monomelic Neuropathy
Larry A. Scher, MD, FACS, Montefiore Medical Center, Rye, NY 

2:30 pm
Balloon Angioplasty Maturation of Acrteriovenous Fistule
Thomas F. Panetta, MD, SUNY Downstate Medical Center, Great Neck, NY 

2:40 pm
Is BAM a Sham? The Clinical Utility of a New Office-Based Procedure
Anil P. Hingorani, MD, FACS, Maimonides Medical Center, Brooklyn, NY 

2:50 pm
PD – the Good Catheter
Joseph J. Naoum, MD, The Methodist Hospital, Houston, TX

3:00 pm
Troubleshooting the HeRO Catheter      
Marc H. Glickman, MD, Vascular & Transplant Specialists, Virginia Beach, VA

3:10 pm
Panel Discussion

3:25 pm
Break

3:45pm
Bleeding Access Site
Mark G. Davies, MD, PhD, Methodist DeBakey Heart and Vascular Center, Houston,
TX

3:55 pm
Salvaging the Unsalvageable Access      
Joseph J. Naoum, MD, The Methodist Hospital, Houston, TX

4:05 pm
Dialysis Access in the Obese                  
Ingemar J. Davidson, MD, PhD, FACS, Southwestern Medical Center, Dallas, TX

4:15 pm
Dialysis Access in the Elderly                  
William C. Jennings, MD, University of Oklahoma College of Medicine, Tulsa, OK

4:25 pm
Lessons from the DAC Trials
Thomas S. Huber, MD, University of Florida, Gainesville, FL

4:35 pm
Coding and Reimbursement
Sean P. Roddy, MD, The Vascular Group, PLLC, Albany, NY

4:45 pm
Panel Discussion

2:00 pm - 5:00 pm
P6: Advanced Techniques for Embolization and Foreign Body Retrievals
Room: 450b

At the end of this session, participants should be able to: 
  1. Report type 2 endoleak as an important risk factor for late endograft failure – mortality.
  2. Develop preemptive strategies to curtail endoleaks.
  3. Explain the different strategies to identify the endoleak.
  4. Discuss transarterial and translumbar approaches.
  5. Employ the use of microcoils and polymers / glue.
  6. Identify complicated iliac artery anatomy / pathology and develop strategies to prevent endoleaks.
  7. Describe the treatment options and techniques for concomitant or metachronous visceral artery aneurysms.
  8. Evaluate that medical implant devices might fail and their risk for embolization.
Moderators: Irwin M. Best, MD, Emory University Hospital, Atlanta, GA
Cynthia K. Shortell, MD, Duke University Medical Center, Durham, NC

2:00 pm
Overview: Type 2 Endoleaks in Large Series Incidence, Re-Intervention, and Mortality Rates
Mark G. Davies, MD, PhD, Methodist DeBakey Heart and Vascular Center, Houston, TX

2:15 pm
Incidence of Type 2 Endoleaks in a Tertiary Center: Our Evaluation and Treatment
Karthikeshwa Kasirajan, MD, Emory University Hospital, Atlanta, GA

2:30 pm
Strategies to Prevent Type 2 Endoleaks from Lumbar, IMA, Internal Iliac Vessels; Intra-Arterial or Translumbar Approaches to Type 2 Endoleaks - Coils or Glue: What Works
Virendra I. Patel, MD, Massachusetts General Hospital, Boston, MA

2:45 pm
Panel Discussion

3:00 pm
Late Ruptures and Mortality? Is a Conservative Approach Justified? 
Edward Y. Woo, MD, Hospital of the University of Pennsylvania, Philadelphia, PA

3:15 pm
Visceral Artery Aneurysm Management
Ross Milner, Loyola University Medical Center, Maywood, IL

3:30 pm
Preoperative Management of the Hypogastric Arteries – Benefits, Risks and Complications - Is There a Role for Laparoscopic / Robotics Approaches to Type 2 Endoleaks?
Ravi K. Veeraswamy, MD, Emory University Hospital, Atlanta, GA
 
3:45 pm
Panel Discussion

4:00 pm
Tran-Arterial and Trans-Venous Recovery of Missiles and Projectiles
David L. Gillespie, MD, University of Rochester, Rochester, NY

4:15 pm
Endovascular Recovery of Migrated / Dislodged / Wires/ Malpositioned Stents / Medical Devices
Mitchell W. Cox, MD, Duke University Medical Center, Durham, NC

4:30 pm
Temporary IVC Filters – Why and When Should They be Removed? Techniques for Difficult IVC Filter Retrieval
Christopher J. Kwolek, MD, Massachusetts General Hospital, Boston, MA

4:45 pm
Panel Discussion
8:00 am – Noon​ General Surgery Resident / Medical Student Scholarship Program Open and Endovascular Simulation Training (scholarship recipients only)
Noon – 1:00 pm​ General Surgery Resident / Medical Student Scholarship Program Lunch
(scholarship recipients only)
Noon – 7:00 pm​ V1: Peripheral Vascular Surgical Society Paper Session I
Room: 353b


At the end of this session, the participant will be able to:

  1. Gain insight into recent developments with respect to diagnostic imaging and percutaneous therapies for carotid, mesenteric, renal and lower extremity vasculature.
  2. Obtain additional understanding with regard to expected outcomes following open and endovascular techniques used to treat abdominal aortic aneurysms, lower extremity revascularization, and combat related vascular injuries in a contemporary setting.
  3. Apply up to date results in day to day practice to maximize success with contemporary open and endovascular techniques across various vascular territories.
  4. Appreciate the impact of streamlining care for patients with ruptured abdominal aortic aneurysms.
Moderators: Kellie Brown, MD, Medical College of Wisconsin, Milwaukee, WI
Jeffery Dattilo, MD, Vanderbilt University Medical Center, Nashville, TN 
PVSS1. Ultrasonic Monitoring of 3-Dimensional Carotid Atherosclerotic Plaque Structure
Brajesh K. Lal1, Siddhartha Sikdar2, Limin Zhao1, Kirk Beach3, Daniel Leotta3
1Univ of Maryland, Baltimore, MD; 2George Mason Univ, Fairfax, VA; 3Univ of Washington, Seattle, WA

12:15 pm
PVSS2. APDVS Survey of Knowledge Acquisition and Educational Needs of Vascular Trainees
Michael C. Dalsing1, Michel S. Makaroun2, Linda M. Harris3, Joseph L. Mills4, John Eidt5
1Surgery, Indiana University School of Medicine, Indianapolis, IN; 2University of Pittsburgh Medical Center, Pittsburgh, PA; 3SUNY at Buffalo Graduate Medical, Buffalo, NY; 4Arizona Health Sciences Center, Tucson, AZ; 5Univ of AR for Med Sciences, Little Rock, AR

12:30 pm
PVSS3. Society for Vascular Surgery (SVS) Vascular Registry® Evaluation of Age-Stratified Comparative Effectiveness of Carotid Endarterectomy (CEA) and Carotid Artery Stenting (CAS)
Jeffrey Jim, Brian G Rubin, Joseph J Ricotta, Christopher T Kenwood, Flora S Siami, Gregorio A Sicard
New England Research Institutes, Inc, Watertown, MA

12:45 pm
PVSS4. Decision Analysis of Optimal Access for Mesenteric Interventions
Katherine Gallagher1, Andrew J. Meltzer1, Reid A. Ravin2, Ashley Graham1, Francesco A. Aiello1, Peter H. Connolly1, Darren B. Schneider3, Harry L. Bush3, Rajeev Dayal2
1Weill Cornell/Columbia University, New York, NY; 2Columbia University Hospital, New York, NY; 3Weill Cornell Hospital, New York, NY

1:00 pm
PVSS5. Changes in Kidney Volume After Renal Artery Stenting: Does Stenting Preserve Renal Mass?
Mitchell Plummer, Carlos H. Timaran, Eric Rosero, Jayer Chung, Frank Arko, G. Patrick Clagett, R. James Valentine, Clayton Trimmer, J. Gregory Modrall
Surgery, University of Texas Southwestern Medical Center, Dallas, TX

1:15 pm
PVSS6. Door to Treatment Time - Identifying Opportunities for Process    Improvement: Results from an Institution Based Protocol Caring for Patients with Ruptured Aortic Aneurysms
Raghu  L Motaganahalli, Michael P Murphy, Alan P Sawchuck, Gary W Lemmon, Andreas  Fajardo, George Akingba, Beejay Feliciano, Dolores Cikrit, Cynthia Richardson, Michael C Dalsing
Indiana University School of Medicine, Indianapolis, IN

1:30 pm
PVSS7. The Impact of Adjunctive Iliac Stenting on Femoral-Femoral Bypass in Contemporary Practice
Chetan P. Huded1, David H. Stone2, Philip P. Goodney2, Richard J. Powell2, Brian W. Nolan2, Eva M. Rzucidlo2, Jack L. Cronenwett2, Daniel B. Walsh2
1Dartmouth Medical School, Hanover, NH; 2Dartmouth Hitchcock Medical Center, Lebanon, NH

1:45 pm
PVSS8. Comparison of Early Hemodynamics After Endovascular Therapy and Open Surgical Bypass in Patients with Diabetes and Critical Limb Ischemia: Does Mode of Revascularization Matter?
Luke X. Zhan, Manish Bharara, Matthew White, Sugam Bhatnagar, Janice Thai, Brian Lepow, David G. Armstrong, Joseph L. Mills
University of Arizona/Southern Arizona Limb Salvage Alliance (SALSA), Tucson, AZ
Omar Al-Nouri, Monika Krezalek, Richard Hershberger, Pegge Halandras, Andrew Gassman, Bernadette Aulivola, Ross Milner
Loyola University Medical Center, Maywood, IL

2:15 pm
PVSS10. Clinical Value of CTA in Patients with ≥50% ICA Stenosis by Duplex Ultrasound
Mohammad I. ElSorady, Heather Hall, Vector Bernhard, Hisham Bassiouny
Vascular Surgery and Endovascular Therapy, University of Chicago Hospitals, Chicago, IL

2:30 pm
PVSS11. Assessing Outcomes to Determine Which “Symptoms” Justify Renal Artery Stenting
J. Gregory Modrall, Eric Rosero, Carlos H. Timaran, Thomas Anthony, Jayer Chung, Frank Arko, G. Patrick Clagett, R. James Valentine, Clayton Trimmer
Surgery, University of Texas Southwestern Medical Center, Dallas, TX

2:45 pm
PVSS12. Prior Endovascular Intervention Does Not Negatively Impact on Lower Extremity Bypass Procedures
Sikandar Z Khan, Reid Ravin, Benjamin Bradley, In-Kyong Kim, James F McKinsey
Columbia University Medical Center, New York, NY
 
3:00 pm
Colin Meghoo1, James W. Dennis2,  Caroline Tuman1, Raymond Fang1
1Landstuhl Regional Medical Center, Landstuhl, Germany; 2Surgery, University of Florida College of Medicine, Jacksonville, FL

3:30 pm
Coffee Break

Session II
At the end of this session, the participant will be able to:
  1. Obtain a broader understanding regarding potential complications arising related to interventions for venous insufficiency as well as expanded interventions for temporary caval interruption.
  2. Appreciate recent developments within the field of hemodialysis access creation as well as potential complications which may arise and influence patient outcomes.
  3. Gain insight from recent studies describing epidemiologic and medicinal effects of smoking cessation and statin use among patients receiving intervention for aortic aneurysms and lower extremity occlusive disease.
  4. Gain a better perspective regarding expected outcomes with visceral debranching followed by endovascular repair of thoracoabdominal aortic aneurysms. 


Moderators: Joseph Hart, MD, Medical University of South Carolina, Charleston, SC
Michael Lepore, MD, Sarasota Vascular Specialists, Sarasota, FL

4:00 pm
PVSS Academic Award Report

4:30 pm
PVSS15. Risk Factors for Surgical Site Infections and Early Graft Failure Following Dialysis Access Procedures
Dorian J. deFreitas1, David Benkeser2, Ravi Veeraswamy1, Thomas Dodson1, Joseph Ricotta1, Atef Salam1, Karthikeshwar Kasirajan1, Matthew Corriere1
1Emory University and Atlanta VA Medical Center, Atlanta, GA; 2The University of Georgia College of Public Health, Athens, GA

4:45 pm
PVSS16. Effect Of Lipid Modifying Drug Therapy On Aortic Aneurysm Repair 
Gaurav M Parmar, Bruce Lowman, Bart R Combs, Steve M Taylor, Mark A Patterson, Marc A Passman, William D Jordan Jr,
University of Alabama at Birmingham, Birmingham, AL

5:00 pm
PVSS17. Surgical Site Infection in Venous Surgery: The Benefit of a Single Dose of Preoperative Antibiotic
Ranjodh Singh1, Amir Aryaie1, Alok Dwivedi3, Brent Marsden1, Rakesh Shukla3, Alan Annenberg2, Gregory Zenni2, Charles Mesh1
1Department of Surgery, Jewish Hospital, Cincinnati, OH; 2Cardiac, Vascular, and Thoracic Surgeons, Inc., Cincinnati, OH; 3Center for Biostatistical Services, Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH.

5:15 pm
PVSS18. Timing of TEVAR Does Not Influence Mortality After Hybrid Repair of Thoracoabdominal Aneurysms
Nathan J Aranson, Emel Ergul, Virendra I Patel, Glenn M LaMuraglia, Christopher J Kwolek, Richard P Cambria, Mark F Conrad
Massachusetts General Hospital, Boston, MA

5:30 pm
PVSS19. Performing Complete Superficial Vein Ablation in Patients with Obesity and Severe Chronic Venous Disease: Who Benefits?
Frank Vandy, Susan Blackburn, Jess Bloom, Amber Clay, Elaine Fellows, Ken Guire, Michele Kantola, William Laforge, Cathy Stabler, Nicole Baker, Emily Cummings, Lisa Pavone, John Rectenwald, Thomas Wakefield
University of Michigan, Ann Arbor, MI

5:45 pm
PVSS20. Results of an Aggressive Surveillance and Retrieval Protocol for Inferior Vena Cava (IVC) Filter Removal
Elizabeth  Blazick, Mounir J Haurani, Virendra I Patel, Glenn M LaMuraglia, Christopher J Kwolek, Mark F Conrad
Massachusetts General Hospital, Boston, MA

6:00 pm
PVSS21. Caval Perforation by Retrievable IVC Filters and Considerations for Open Explantation
Peter Connolly2, Vinod Balachandran1, Govind Nandakumar1, David Trost1, Darren Schneider1, Harry L. Bush1
1New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY; 2Columbia Presbyterian, New York, NY

6:15 pm
PVSS22. Statin Therapy is Associated with Superior Clinical Outcomes After Endovascular Treatment of Critical Limb Ischemia
Francesco A. Aiello, Muhammad A. Khan, Katherine A. Gallagher, John K. Karwowski, Harry L. Bush, James F. McKinsey, Darren B. Schneider
New York Presbyterian Hospital-Weill Cornell/Columbia University, New York, NY

6:30 pm
PVSS23. PAD Patients who Undergo More Invasive Revascularization Procedures are More Likely to Decrease or Quit Smoking
Sareh Rajaee, Edward J. Marcaccio, Wilfred I. Carney, Tze Tec Chong, Manuel Garcia-Toca, Jeffrey M. Slaiby
Department of Vascular Surgery, Warren Alpert Medical School at Brown University, Providence, RI

6:45 pm
PVSS24. Duplex-Guided Office Based Arterio-Venous Fistula Thrombectomy: A Novel Technique
Anil Hingorani
Division of Vascular Services, Maimonides Medical Center, Brooklyn, NY
12:00 pm – 7:30 pm Vascular Annual Meeting Registration Open
Room: Level 2 Lobby
3:00 pm – 7:00 pm​
Room: 351

3:00 pm
Presidential Address
Enrico Ascher, MD, Maimonides Medical Center, Brooklyn, NY, USA

Session I
Moderators: Enrico Ascher, MD, Maimonides Medical Center, Brooklyn, NY, USA
John H. Wolfe MD, St. Mary’s Hospital, London, England

At the end of this session, participatns should be able to:
  1. Discuss the immunohistochemical study of endarteritis obliterans in the pathogenesis of Buerger’s disease.
  2. Compare the advantages and disadvantages of surgical revascularization for CLI.
  3. Describe the rationale for and development of a bi-national Australasian vascular audit.
  4. Explain the beginning of vascular surgery in South Africa.
  5. Select the appropriate treatment for complex aortic aneurysms.
  6. Define early treatment for type B aortic dissections.
  7. Explain how randomized trials can be misinterpreted in leading journals.
3:13 pm
Japan
Endarteritis Obliterans in the Pathogenesis of Buerger’s Disease: An Immunohistochemical Study
Masayoshi Kobayashi, MD, PhD, Division of Vascular Surgery, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya City, Japan

3:26 pm
United States
Surgical Revascularization for CLI: A Critical Appraisal
Michael S. Conte, MD, University of California, San Francisco, CA

3:39 pm
Australia
The Rationale for and Development of a Bi-National Australasian Vascular Audit
Robert Fitridge, MD, The Queen Elizabeth Hospital, Woodville, Australia

3:52 pm
South Africa
Robert Goetz, the Giraffe, the World’s First Coronary Bypass and the Birth of Vascular Surgery in South Africa
Philip Matley, MBChB, MMED, FCS, Cape Doctor, Cape Town, Western Cape, South Africa

4:05 pm
Brazil
The Sandwich Technique and Other Innovations in the Treatment of Complex Aortic Aneurysms 
Armando C. Lobato, MD, PhD, Instituto de Cirurgia Vascular e Endovascular de Sao Paulo, Brazil

4:18 pm
England
Defining Early Treatment of Type B Aortic Dissections: Advancing Technology in Investigation and Treatment
Richard Gibbs, MD, Imperial College, London, England

4:31 pm
The Robert B. Rutherford Award:
How Can Good Randomized Trials Be So Misinterpreted In Leading Journals?
Frank J. Veith, MD, The Cleveland Clinic, Cleveland, OH, USA
 
4:51 pm
Coffee Break
 
Session II
At the end of this session, participants should be able to:
  1. Discuss the methodology, results, and conclusions of the research presented in vascular health.
  2. Gain knowledge of new technology for diagnosis and treatment of vascular disease.

Moderators: Robert Fitridge, MD, The Queen Elizabeth Hospital, Woodville, Australia
Martin Veller, MD, University of Witwatersrand, Johannesburg, South Africa

5:15 pm
WF1. Neurological Symptoms Before or After the Qualifying Event for Carotidendarterectomy? A National Audit
Björn Kragsterman, Nakisa Esfahani, Annika Boström-Ardin, Martin Björck
Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden
Jonathan Beard and Anup Mathew
Sheffield Vascular Institute on behalf of the Vascular Society of Great Britain and Ireland
Hafees Saleem 1,2, Christopher Delaney 1,2, Phillip Puckridge 1,1, J. Ian Spark 1.2
1Flinders Medical Centre, 2Flinders University, Adelaide, Australia

5:51 pm
WF4. N-Terminal Pro B-Type Natriuretic Peptide (NT pro-BNP) is a Predictor of Long Term Survival in Male Patients of 75 Years and Older with High Grade Asymptomatic Internal Carotid Artery Stenosis
Nikolaus Duschek1, Edda Skrinjar1, Thomas Waldhör2, Christian Vutuc2, Gerhard Daniel3, Wolfgang Hübl4, Afshin Assadian1
1 Department of General and Vascular Surgery, Wilhelminenspital, Vienna, Austria, 2Department of Epidemiology, Center for Public Health, Medical University of Vienna, Vienna, Austria, 3Department of Neurology, Wilhelminenspital, Vienna, Austria, 4Department of Laboratory Medicine, Wilhelminenspital, Vienna, Austria

6:03 pm
WF5. The Role of Flexible Robotics in Overcoming Navigation Challenges in the Iliofemoral Arteries; A First-in-Man Study
Jean Bismuth, Milenko Stankovic, Borut Gersak, Alan B. Lumsden
The Methodist Hospital System, Houston, TX, USA 

6:15 pm
WF6. Remote Ischaemic Preconditioning in Peripheral Artery Endovascular Intervention
Jeanne Adele Lubbe, Daniel du Toit, EJ Honiball, BL Warren 
Division of Surgery, University of Stellenbosch, South Africa

6:27 pm
WF7. The Changing Management of Primary Mycotic Aortic Aneurysms
Nadia Vallejo, Natasha Picardo, Elika Kashef, P. Bourke, Corin D. Bicknell, NJW Cheshire, MP Jenkins, JHN Wolfe, Richard Gibbs
St Mary's Hospital, London, England

6:39 pm
WF8. Intraoperative Blood Transfusion is a Risk Factor for Stroke in Patients Undergoing Carotid Endarterectomy
Elftherios Xenos; Chen Rubinstein; Daniel Davenport
University of Kentucky, Lexington, KY, USA

6:51 pm
Closing Comments
Enrico Ascher, MD, Maimonides Medical Center, Brooklyn, NY
Robert Fitridge, MD, The Queen Elizabeth Hospital, Woodville, Australia​
 

 Updated June 2011

Contact Us

Society for Vascular Surgery
633 North Saint Clair Street, 22nd Floor | Chicago, IL 60611
Phone: 312-334-2300 | 800-258-7188
Fax: 312-334-2320
Email: vascular@vascularsociety.org

Follow Us

YouTube

VascularWeb® is the prime source for all vascular health and disease information, and is presented by the Society for Vascular Surgery®. Its members are vascular surgeons, specialists, and vascular health professionals who are specialty-trained in all treatments for vascular disease including medical management, non-invasive procedures, and surgery.